Loading…
The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling
Biomarkers in dilated cardiomyopathy (DCM) reflect various pathobiological processes, including neurohormonal activation, oxidative stress, matrix remodeling, myocyte injury and myocyte stretch. We assessed the role of biomarkers in clinical and echocardiographic parameters and in left ventricular (...
Saved in:
| Published in: | Revista portuguesa de cardiologia 2017-10, Vol.36 (10), p.709-716 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c466t-990e4fdaa9c13707016fb1636447fc0caf6159b9de22c1a1448cf773a137ef693 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c466t-990e4fdaa9c13707016fb1636447fc0caf6159b9de22c1a1448cf773a137ef693 |
| container_end_page | 716 |
| container_issue | 10 |
| container_start_page | 709 |
| container_title | Revista portuguesa de cardiologia |
| container_volume | 36 |
| creator | Amorim, Sandra Campelo, Manuel Moura, Brenda Martins, Elisabete Rodrigues, João Barroso, Isaac Faria, Margarida Guimarães, Tiago Macedo, Filipe Silva-Cardoso, José Maciel, Maria Júlia |
| description | Biomarkers in dilated cardiomyopathy (DCM) reflect various pathobiological processes, including neurohormonal activation, oxidative stress, matrix remodeling, myocyte injury and myocyte stretch. We assessed the role of biomarkers in clinical and echocardiographic parameters and in left ventricular (LV) reverse remodeling (LVRR).
In this prospective study of 50 DCM patients (28 men, aged 59±10 years) with LV ejection fraction (LVEF) 10 U in LVEF after optimal medical therapy.
Baseline LVEF was 25.4±9.8% and LV end-diastolic diameter (LVEDD)/body surface area (BSA) was 34.2±4.5 mm/m2. LVRR occurred in 34% of patients within 17.6±15.6 months. No correlation was found between B-type natriuretic peptide (BNP), 25-hydroxyvitamin D (25(OH)D), CA-125, high-sensitivity C-reactive protein (hs-CRP), lipoprotein(a) [Lp(a)], noradrenaline, adrenaline, renin or aldosterone and LVRR. Patients in NYHA class III or IV, with pulmonary congestion or ankle edema, had higher CA-125, cystatin C, BNP and hs-CRP levels (p |
| doi_str_mv | 10.1016/j.repc.2017.02.015 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c1369bf9e965479ba7e58ed94c158f99</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0870255117306546</els_id><doaj_id>oai_doaj_org_article_c1369bf9e965479ba7e58ed94c158f99</doaj_id><sourcerecordid>1949083185</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-990e4fdaa9c13707016fb1636447fc0caf6159b9de22c1a1448cf773a137ef693</originalsourceid><addsrcrecordid>eNp9kcFvFCEYxYnR2E3tP-DBcPQy4wfDwGC8NE3VJk281DNh4KPLOjusMNtk_3sZt_YoFwL83vvyeIS8Z9AyYPLTrs14cC0HplrgLbD-FdlwpkTDoYPXZAODgob3PbsgV6XsoC4JTHfyLbnggx40SL0h24ct0pwmpCnQMaa9zb8wFxpn6uNkF_TU2ezrwykd7LI9fabXpWApe5yXVeOmOEdnJ1rwCXNcTtTOnub1UKoz7pPHijy-I2-CnQpePe-X5OfX24eb7839j293N9f3jRNSLo3WgCJ4a7VjnQJVo4aRyU4KoYIDZ4NkvR61R84ds0yIwQWlOltpDFJ3l-Tu7OuT3ZlDjjXRySQbzd-LlB-NzUt0E5o6QeoxaNSyF0qPVmE_oNfCsX4IevX6ePY65PT7iGUx-1gcTpOdMR2LYVpoGDo29BXlZ9TlVErG8DKagVkLMzuzFmbWwgxwUwurog_P_sdxj_5F8q-eCnw5A1h_7CliNsVFnB36mNEtNVL8n_8f802nYg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1949083185</pqid></control><display><type>article</type><title>The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling</title><source>ScienceDirect (Online service)</source><creator>Amorim, Sandra ; Campelo, Manuel ; Moura, Brenda ; Martins, Elisabete ; Rodrigues, João ; Barroso, Isaac ; Faria, Margarida ; Guimarães, Tiago ; Macedo, Filipe ; Silva-Cardoso, José ; Maciel, Maria Júlia</creator><creatorcontrib>Amorim, Sandra ; Campelo, Manuel ; Moura, Brenda ; Martins, Elisabete ; Rodrigues, João ; Barroso, Isaac ; Faria, Margarida ; Guimarães, Tiago ; Macedo, Filipe ; Silva-Cardoso, José ; Maciel, Maria Júlia</creatorcontrib><description><![CDATA[Biomarkers in dilated cardiomyopathy (DCM) reflect various pathobiological processes, including neurohormonal activation, oxidative stress, matrix remodeling, myocyte injury and myocyte stretch. We assessed the role of biomarkers in clinical and echocardiographic parameters and in left ventricular (LV) reverse remodeling (LVRR).
In this prospective study of 50 DCM patients (28 men, aged 59±10 years) with LV ejection fraction (LVEF) <40%, LVRR was defined as an increase of >10 U in LVEF after optimal medical therapy.
Baseline LVEF was 25.4±9.8% and LV end-diastolic diameter (LVEDD)/body surface area (BSA) was 34.2±4.5 mm/m2. LVRR occurred in 34% of patients within 17.6±15.6 months. No correlation was found between B-type natriuretic peptide (BNP), 25-hydroxyvitamin D (25(OH)D), CA-125, high-sensitivity C-reactive protein (hs-CRP), lipoprotein(a) [Lp(a)], noradrenaline, adrenaline, renin or aldosterone and LVRR. Patients in NYHA class III or IV, with pulmonary congestion or ankle edema, had higher CA-125, cystatin C, BNP and hs-CRP levels (p<0.05). CA-125 was correlated with BNP (r=0.61), hs-CRP (r=0.56) and uric acid (r=0.52) (all p=0.01). BNP correlated directly with LVEDD (r=0.49), LV volumes (r=0.51), pulmonary artery systolic pressure (PASP) (r=0.43) and E/e′ (r=0.31), and was inversely correlated with LVEF (r=-0.50) and e′ velocity (r=-0.32) (p<0.05). CA-125 was positively correlated with left atrial volume/BSA (r=0.46), E/A ratio (r=0.60) and PASP (r=0.49) (p<0.05).
No correlation was found between biomarkers and LVRR, but CA-125, BNP and hs-CRP were predictors of clinical severity and congestion. BNP correlated with parameters of systolic and diastolic dysfunction, while CA-125 correlated with measures of diastolic dysfunction.
Os biomarcadores na miocardiopatia dilatada (DCM) refletem vários processos fisiopatológicos: ativação neuro-hormonal, stresse oxidativo, remodelagem da matriz extracelular, lesão e estiramento miocitários. Procurámos associar biomarcadores com parâmetros clínicos, ecocardiográficos e com a reversão da remodelagem do ventrículo esquerdo (LVRR).
Estudo prospetivo de 50 doentes com DCM (28 homens, idade 59±10 anos) com fração de ejeção ventricular esquerda (LVEF) <40%. A LVRR definiu-se como aumento>10 U da LVEF, após a terapêutica médica otimizada.
A LVEF basal foi de 25,4±9,8% e o diâmetro do VE (LVD)/BSA de 34,2±4,5 mm/m2. A LVRR ocorreu em 34%, em 17,6±15,6 meses. Não houve correlação entre BNP, 25-OH-vit D, CA 125, hsCRP, Lp(a), noradrenalina, adrenalina, renina, aldosterona e LVRR. Doentes em classe NYHA (III-IV), com congestão pulmonar ou edema periférico apresentaram níveis mais elevados de CA 125, cistatina C, BNP e hsCRP (p<0,05). O CA 125 correlacionou-se com níveis de BNP (r=0,61), hsCRP (r=0,56) e ácido úrico (r=0,52) (p=0,01). O BNP relacionou-se diretamente com LVD (r=0,49), volume VE (r=0,51), PSAP (r=0,43), razão E/e′ (r=0,31); e inversamente com LVEF (r=-0,50) e vel. e′ (r=-0,32) (p<0,05). O CA 125 correlacionou-se com o volume AE/BSA (r=0,46), razão E/A (r=0,60) e PSAP (r=0,49) (p<0,05).
Não houve correlação entre biomarcadores e LVRR, contudo, o CA125, BNP e hsCRP foram preditores de gravidade clínica e de congestão. O BNP relacionou-se com parâmetros de disfunção sistólica e diastólica, enquanto o CA 125 se relacionou com medidas de disfunção diastólica.]]></description><identifier>ISSN: 0870-2551</identifier><identifier>EISSN: 2174-2030</identifier><identifier>DOI: 10.1016/j.repc.2017.02.015</identifier><identifier>PMID: 28989069</identifier><language>eng</language><publisher>Portugal: Elsevier España, S.L.U</publisher><subject>Biomarcadores ; Biomarkers ; Biomarkers - blood ; Cardiomyopathy, Dilated - blood ; Cardiomyopathy, Dilated - diagnostic imaging ; Dilated cardiomyopathy ; Echocardiography ; Female ; Humans ; Male ; Middle Aged ; Miocardiopatia dilatada ; Prospective Studies ; Remodelagem reversa ; Reverse remodeling ; Severity of Illness Index ; Ventricular Remodeling</subject><ispartof>Revista portuguesa de cardiologia, 2017-10, Vol.36 (10), p.709-716</ispartof><rights>2017 Sociedade Portuguesa de Cardiologia</rights><rights>Copyright © 2017 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-990e4fdaa9c13707016fb1636447fc0caf6159b9de22c1a1448cf773a137ef693</citedby><cites>FETCH-LOGICAL-c466t-990e4fdaa9c13707016fb1636447fc0caf6159b9de22c1a1448cf773a137ef693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0870255117306546$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28989069$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Amorim, Sandra</creatorcontrib><creatorcontrib>Campelo, Manuel</creatorcontrib><creatorcontrib>Moura, Brenda</creatorcontrib><creatorcontrib>Martins, Elisabete</creatorcontrib><creatorcontrib>Rodrigues, João</creatorcontrib><creatorcontrib>Barroso, Isaac</creatorcontrib><creatorcontrib>Faria, Margarida</creatorcontrib><creatorcontrib>Guimarães, Tiago</creatorcontrib><creatorcontrib>Macedo, Filipe</creatorcontrib><creatorcontrib>Silva-Cardoso, José</creatorcontrib><creatorcontrib>Maciel, Maria Júlia</creatorcontrib><title>The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling</title><title>Revista portuguesa de cardiologia</title><addtitle>Rev Port Cardiol</addtitle><description><![CDATA[Biomarkers in dilated cardiomyopathy (DCM) reflect various pathobiological processes, including neurohormonal activation, oxidative stress, matrix remodeling, myocyte injury and myocyte stretch. We assessed the role of biomarkers in clinical and echocardiographic parameters and in left ventricular (LV) reverse remodeling (LVRR).
In this prospective study of 50 DCM patients (28 men, aged 59±10 years) with LV ejection fraction (LVEF) <40%, LVRR was defined as an increase of >10 U in LVEF after optimal medical therapy.
Baseline LVEF was 25.4±9.8% and LV end-diastolic diameter (LVEDD)/body surface area (BSA) was 34.2±4.5 mm/m2. LVRR occurred in 34% of patients within 17.6±15.6 months. No correlation was found between B-type natriuretic peptide (BNP), 25-hydroxyvitamin D (25(OH)D), CA-125, high-sensitivity C-reactive protein (hs-CRP), lipoprotein(a) [Lp(a)], noradrenaline, adrenaline, renin or aldosterone and LVRR. Patients in NYHA class III or IV, with pulmonary congestion or ankle edema, had higher CA-125, cystatin C, BNP and hs-CRP levels (p<0.05). CA-125 was correlated with BNP (r=0.61), hs-CRP (r=0.56) and uric acid (r=0.52) (all p=0.01). BNP correlated directly with LVEDD (r=0.49), LV volumes (r=0.51), pulmonary artery systolic pressure (PASP) (r=0.43) and E/e′ (r=0.31), and was inversely correlated with LVEF (r=-0.50) and e′ velocity (r=-0.32) (p<0.05). CA-125 was positively correlated with left atrial volume/BSA (r=0.46), E/A ratio (r=0.60) and PASP (r=0.49) (p<0.05).
No correlation was found between biomarkers and LVRR, but CA-125, BNP and hs-CRP were predictors of clinical severity and congestion. BNP correlated with parameters of systolic and diastolic dysfunction, while CA-125 correlated with measures of diastolic dysfunction.
Os biomarcadores na miocardiopatia dilatada (DCM) refletem vários processos fisiopatológicos: ativação neuro-hormonal, stresse oxidativo, remodelagem da matriz extracelular, lesão e estiramento miocitários. Procurámos associar biomarcadores com parâmetros clínicos, ecocardiográficos e com a reversão da remodelagem do ventrículo esquerdo (LVRR).
Estudo prospetivo de 50 doentes com DCM (28 homens, idade 59±10 anos) com fração de ejeção ventricular esquerda (LVEF) <40%. A LVRR definiu-se como aumento>10 U da LVEF, após a terapêutica médica otimizada.
A LVEF basal foi de 25,4±9,8% e o diâmetro do VE (LVD)/BSA de 34,2±4,5 mm/m2. A LVRR ocorreu em 34%, em 17,6±15,6 meses. Não houve correlação entre BNP, 25-OH-vit D, CA 125, hsCRP, Lp(a), noradrenalina, adrenalina, renina, aldosterona e LVRR. Doentes em classe NYHA (III-IV), com congestão pulmonar ou edema periférico apresentaram níveis mais elevados de CA 125, cistatina C, BNP e hsCRP (p<0,05). O CA 125 correlacionou-se com níveis de BNP (r=0,61), hsCRP (r=0,56) e ácido úrico (r=0,52) (p=0,01). O BNP relacionou-se diretamente com LVD (r=0,49), volume VE (r=0,51), PSAP (r=0,43), razão E/e′ (r=0,31); e inversamente com LVEF (r=-0,50) e vel. e′ (r=-0,32) (p<0,05). O CA 125 correlacionou-se com o volume AE/BSA (r=0,46), razão E/A (r=0,60) e PSAP (r=0,49) (p<0,05).
Não houve correlação entre biomarcadores e LVRR, contudo, o CA125, BNP e hsCRP foram preditores de gravidade clínica e de congestão. O BNP relacionou-se com parâmetros de disfunção sistólica e diastólica, enquanto o CA 125 se relacionou com medidas de disfunção diastólica.]]></description><subject>Biomarcadores</subject><subject>Biomarkers</subject><subject>Biomarkers - blood</subject><subject>Cardiomyopathy, Dilated - blood</subject><subject>Cardiomyopathy, Dilated - diagnostic imaging</subject><subject>Dilated cardiomyopathy</subject><subject>Echocardiography</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Miocardiopatia dilatada</subject><subject>Prospective Studies</subject><subject>Remodelagem reversa</subject><subject>Reverse remodeling</subject><subject>Severity of Illness Index</subject><subject>Ventricular Remodeling</subject><issn>0870-2551</issn><issn>2174-2030</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kcFvFCEYxYnR2E3tP-DBcPQy4wfDwGC8NE3VJk281DNh4KPLOjusMNtk_3sZt_YoFwL83vvyeIS8Z9AyYPLTrs14cC0HplrgLbD-FdlwpkTDoYPXZAODgob3PbsgV6XsoC4JTHfyLbnggx40SL0h24ct0pwmpCnQMaa9zb8wFxpn6uNkF_TU2ezrwykd7LI9fabXpWApe5yXVeOmOEdnJ1rwCXNcTtTOnub1UKoz7pPHijy-I2-CnQpePe-X5OfX24eb7839j293N9f3jRNSLo3WgCJ4a7VjnQJVo4aRyU4KoYIDZ4NkvR61R84ds0yIwQWlOltpDFJ3l-Tu7OuT3ZlDjjXRySQbzd-LlB-NzUt0E5o6QeoxaNSyF0qPVmE_oNfCsX4IevX6ePY65PT7iGUx-1gcTpOdMR2LYVpoGDo29BXlZ9TlVErG8DKagVkLMzuzFmbWwgxwUwurog_P_sdxj_5F8q-eCnw5A1h_7CliNsVFnB36mNEtNVL8n_8f802nYg</recordid><startdate>201710</startdate><enddate>201710</enddate><creator>Amorim, Sandra</creator><creator>Campelo, Manuel</creator><creator>Moura, Brenda</creator><creator>Martins, Elisabete</creator><creator>Rodrigues, João</creator><creator>Barroso, Isaac</creator><creator>Faria, Margarida</creator><creator>Guimarães, Tiago</creator><creator>Macedo, Filipe</creator><creator>Silva-Cardoso, José</creator><creator>Maciel, Maria Júlia</creator><general>Elsevier España, S.L.U</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>201710</creationdate><title>The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling</title><author>Amorim, Sandra ; Campelo, Manuel ; Moura, Brenda ; Martins, Elisabete ; Rodrigues, João ; Barroso, Isaac ; Faria, Margarida ; Guimarães, Tiago ; Macedo, Filipe ; Silva-Cardoso, José ; Maciel, Maria Júlia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-990e4fdaa9c13707016fb1636447fc0caf6159b9de22c1a1448cf773a137ef693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Biomarcadores</topic><topic>Biomarkers</topic><topic>Biomarkers - blood</topic><topic>Cardiomyopathy, Dilated - blood</topic><topic>Cardiomyopathy, Dilated - diagnostic imaging</topic><topic>Dilated cardiomyopathy</topic><topic>Echocardiography</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Miocardiopatia dilatada</topic><topic>Prospective Studies</topic><topic>Remodelagem reversa</topic><topic>Reverse remodeling</topic><topic>Severity of Illness Index</topic><topic>Ventricular Remodeling</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Amorim, Sandra</creatorcontrib><creatorcontrib>Campelo, Manuel</creatorcontrib><creatorcontrib>Moura, Brenda</creatorcontrib><creatorcontrib>Martins, Elisabete</creatorcontrib><creatorcontrib>Rodrigues, João</creatorcontrib><creatorcontrib>Barroso, Isaac</creatorcontrib><creatorcontrib>Faria, Margarida</creatorcontrib><creatorcontrib>Guimarães, Tiago</creatorcontrib><creatorcontrib>Macedo, Filipe</creatorcontrib><creatorcontrib>Silva-Cardoso, José</creatorcontrib><creatorcontrib>Maciel, Maria Júlia</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Directory of Open Access Journals</collection><jtitle>Revista portuguesa de cardiologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Amorim, Sandra</au><au>Campelo, Manuel</au><au>Moura, Brenda</au><au>Martins, Elisabete</au><au>Rodrigues, João</au><au>Barroso, Isaac</au><au>Faria, Margarida</au><au>Guimarães, Tiago</au><au>Macedo, Filipe</au><au>Silva-Cardoso, José</au><au>Maciel, Maria Júlia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling</atitle><jtitle>Revista portuguesa de cardiologia</jtitle><addtitle>Rev Port Cardiol</addtitle><date>2017-10</date><risdate>2017</risdate><volume>36</volume><issue>10</issue><spage>709</spage><epage>716</epage><pages>709-716</pages><issn>0870-2551</issn><eissn>2174-2030</eissn><abstract><![CDATA[Biomarkers in dilated cardiomyopathy (DCM) reflect various pathobiological processes, including neurohormonal activation, oxidative stress, matrix remodeling, myocyte injury and myocyte stretch. We assessed the role of biomarkers in clinical and echocardiographic parameters and in left ventricular (LV) reverse remodeling (LVRR).
In this prospective study of 50 DCM patients (28 men, aged 59±10 years) with LV ejection fraction (LVEF) <40%, LVRR was defined as an increase of >10 U in LVEF after optimal medical therapy.
Baseline LVEF was 25.4±9.8% and LV end-diastolic diameter (LVEDD)/body surface area (BSA) was 34.2±4.5 mm/m2. LVRR occurred in 34% of patients within 17.6±15.6 months. No correlation was found between B-type natriuretic peptide (BNP), 25-hydroxyvitamin D (25(OH)D), CA-125, high-sensitivity C-reactive protein (hs-CRP), lipoprotein(a) [Lp(a)], noradrenaline, adrenaline, renin or aldosterone and LVRR. Patients in NYHA class III or IV, with pulmonary congestion or ankle edema, had higher CA-125, cystatin C, BNP and hs-CRP levels (p<0.05). CA-125 was correlated with BNP (r=0.61), hs-CRP (r=0.56) and uric acid (r=0.52) (all p=0.01). BNP correlated directly with LVEDD (r=0.49), LV volumes (r=0.51), pulmonary artery systolic pressure (PASP) (r=0.43) and E/e′ (r=0.31), and was inversely correlated with LVEF (r=-0.50) and e′ velocity (r=-0.32) (p<0.05). CA-125 was positively correlated with left atrial volume/BSA (r=0.46), E/A ratio (r=0.60) and PASP (r=0.49) (p<0.05).
No correlation was found between biomarkers and LVRR, but CA-125, BNP and hs-CRP were predictors of clinical severity and congestion. BNP correlated with parameters of systolic and diastolic dysfunction, while CA-125 correlated with measures of diastolic dysfunction.
Os biomarcadores na miocardiopatia dilatada (DCM) refletem vários processos fisiopatológicos: ativação neuro-hormonal, stresse oxidativo, remodelagem da matriz extracelular, lesão e estiramento miocitários. Procurámos associar biomarcadores com parâmetros clínicos, ecocardiográficos e com a reversão da remodelagem do ventrículo esquerdo (LVRR).
Estudo prospetivo de 50 doentes com DCM (28 homens, idade 59±10 anos) com fração de ejeção ventricular esquerda (LVEF) <40%. A LVRR definiu-se como aumento>10 U da LVEF, após a terapêutica médica otimizada.
A LVEF basal foi de 25,4±9,8% e o diâmetro do VE (LVD)/BSA de 34,2±4,5 mm/m2. A LVRR ocorreu em 34%, em 17,6±15,6 meses. Não houve correlação entre BNP, 25-OH-vit D, CA 125, hsCRP, Lp(a), noradrenalina, adrenalina, renina, aldosterona e LVRR. Doentes em classe NYHA (III-IV), com congestão pulmonar ou edema periférico apresentaram níveis mais elevados de CA 125, cistatina C, BNP e hsCRP (p<0,05). O CA 125 correlacionou-se com níveis de BNP (r=0,61), hsCRP (r=0,56) e ácido úrico (r=0,52) (p=0,01). O BNP relacionou-se diretamente com LVD (r=0,49), volume VE (r=0,51), PSAP (r=0,43), razão E/e′ (r=0,31); e inversamente com LVEF (r=-0,50) e vel. e′ (r=-0,32) (p<0,05). O CA 125 correlacionou-se com o volume AE/BSA (r=0,46), razão E/A (r=0,60) e PSAP (r=0,49) (p<0,05).
Não houve correlação entre biomarcadores e LVRR, contudo, o CA125, BNP e hsCRP foram preditores de gravidade clínica e de congestão. O BNP relacionou-se com parâmetros de disfunção sistólica e diastólica, enquanto o CA 125 se relacionou com medidas de disfunção diastólica.]]></abstract><cop>Portugal</cop><pub>Elsevier España, S.L.U</pub><pmid>28989069</pmid><doi>10.1016/j.repc.2017.02.015</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0870-2551 |
| ispartof | Revista portuguesa de cardiologia, 2017-10, Vol.36 (10), p.709-716 |
| issn | 0870-2551 2174-2030 |
| language | eng |
| recordid | cdi_doaj_primary_oai_doaj_org_article_c1369bf9e965479ba7e58ed94c158f99 |
| source | ScienceDirect (Online service) |
| subjects | Biomarcadores Biomarkers Biomarkers - blood Cardiomyopathy, Dilated - blood Cardiomyopathy, Dilated - diagnostic imaging Dilated cardiomyopathy Echocardiography Female Humans Male Middle Aged Miocardiopatia dilatada Prospective Studies Remodelagem reversa Reverse remodeling Severity of Illness Index Ventricular Remodeling |
| title | The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T11%3A25%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20biomarkers%20in%20dilated%20cardiomyopathy:%20Assessment%20of%20clinical%20severity%20and%20reverse%20remodeling&rft.jtitle=Revista%20portuguesa%20de%20cardiologia&rft.au=Amorim,%20Sandra&rft.date=2017-10&rft.volume=36&rft.issue=10&rft.spage=709&rft.epage=716&rft.pages=709-716&rft.issn=0870-2551&rft.eissn=2174-2030&rft_id=info:doi/10.1016/j.repc.2017.02.015&rft_dat=%3Cproquest_doaj_%3E1949083185%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c466t-990e4fdaa9c13707016fb1636447fc0caf6159b9de22c1a1448cf773a137ef693%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1949083185&rft_id=info:pmid/28989069&rfr_iscdi=true |